Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap5.43B
Enterprise Value4.92B
P/E Ratio-42.63
PEG Ratio2.4
Price/Sales Ratio7.25
Price/Book Ratio3.12
Enterprise/Revenue6.48
Enterprise/EBITDA-52.74

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.17
Operating Margin-0.2
AD

Management Effectiveness

Return On Assets-0.05
Return On Equity-0.07

Income Statement

Revenue768.97M
Revenue/Share0.71
Gross Profit389.07M
EBITDA-79.06M
Net Income-134.71M
Diluted EPS-0.13

Balance Sheet

Total Cash1.08B
Total Cash/Share1.03
Total Debt512.17M
Total Debt/Equity0.3
Current Ratio1.99
Book Value Per Share1.66

Price History

52-Week Change13.02
52-Week High6.86
52-Week Low4.1
Moving Average 50 Days5.15
Moving Average 200 Days5.3

Statistics

Average Volume40M
Shares Outstanding1.06B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.06
Last Split Factor18:5
Last Split DateMay 24, 2016
AD